# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA615192 | F | Cytotoxicity against human ovarian cancer (1A9) cell lines. | Homo sapiens | 6 | ALA1131861 | cell-based format | Scientific Literature | |
2. | ALA619529 | F | Cytotoxicity against human lung carcinoma (A549) cell lines | Homo sapiens | 3 | ALA1131861 | cell-based format | Scientific Literature | |
3. | ALA654280 | F | Cytotoxicity against human renal cancer(CAKI-1) cell lines; Not active | Homo sapiens | 2 | ALA1131861 | cell-based format | Scientific Literature | |
4. | ALA685451 | F | Cytotoxicity against human ileocecal carcinoma (HCT-8) cell lines; Not tested | Homo sapiens | 2 | ALA1131861 | cell-based format | Scientific Literature | |
5. | ALA700721 | F | Cytotoxicity against human epidermoid carcinoma of the nasopharynx(KB) cell lines. | Homo sapiens | 6 | ALA1131861 | cell-based format | Scientific Literature | |
6. | ALA709295 | F | Cytotoxicity against human breast cancer(MCF-7) cell lines. | Homo sapiens | 6 | ALA1131861 | cell-based format | Scientific Literature | |
7. | ALA805704 | F | Cytotoxicity against human osteosarcoma (SaOS-2) cell lines. | Homo sapiens | 3 | ALA1131861 | cell-based format | Scientific Literature | |
8. | ALA805706 | F | Percentage inhibition of human osteosarcoma (SaOS-2) cell lines. | Homo sapiens | 2 | ALA1131861 | cell-based format | Scientific Literature | |
9. | ALA1228621 | F | Antiinflammatory activity in human foreskin fibroblast assessed as inhibition of IL-1-beta-induced MMP1 production at 1 uM treated for 24 hrs before IL1-beta challenge measured after 24 hrs by Western blot analysis | Homo sapiens | 14 | ALA1221396 | cell-based format | Scientific Literature | |
10. | ALA1228622 | A | Cytotoxicity against human foreskin fibroblast at 1 uM | Homo sapiens | 7 | ALA1221396 | cell-based format | Scientific Literature | |
11. | ALA1944442 | F | Antihyperglycemic activity in ddY mouse assessed as inhibition of sucrose-induced increase in plasma glucose level at 100 mg/kg, po administered 30 mins before sucrose challenge measured after 0.5 hrs (Rvb = 220.5 +/- 16.9 mg/dl) | Mus musculus | 9 | ALA1938306 | organism-based format | Scientific Literature | |
12. | ALA1944443 | F | Antihyperglycemic activity in ddY mouse assessed as inhibition of sucrose-induced increase in plasma glucose level at 100 mg/kg, po administered 30 mins before sucrose challenge measured after 1 hr (Rvb = 221.4 +/- 9.1 mg/dl) | Mus musculus | 9 | ALA1938306 | organism-based format | Scientific Literature | |
13. | ALA1944444 | F | Antihyperglycemic activity in ddY mouse assessed as inhibition of sucrose-induced increase in plasma glucose level at 100 mg/kg, po administered 30 mins before sucrose challenge measured after 2 hrs (Rvb = 160.8 +/- 3.5 mg/dl) | Mus musculus | 9 | ALA1938306 | organism-based format | Scientific Literature | |
14. | ALA1944445 | F | Antihyperglycemic activity in ddY mouse assessed as inhibition of sucrose-induced increase in plasma glucose level at 200 mg/kg, po administered 30 mins before sucrose challenge measured after 0.5 hrs (Rvb = 220.5 +/- 16.9 mg/dl) | Mus musculus | 9 | ALA1938306 | organism-based format | Scientific Literature | |
15. | ALA1944446 | F | Antihyperglycemic activity in ddY mouse assessed as inhibition of sucrose-induced increase in plasma glucose level at 200 mg/kg, po administered 30 mins before sucrose challenge measured after 1 hr (Rvb = 221.4 +/- 9.1 mg/dl) | Mus musculus | 9 | ALA1938306 | organism-based format | Scientific Literature | |
16. | ALA1944447 | F | Antihyperglycemic activity in ddY mouse assessed as inhibition of sucrose-induced increase in plasma glucose level at 200 mg/kg, po administered 30 mins before sucrose challenge measured after 2 hrs (Rvb = 160.8 +/- 3.5 mg/dl) | Mus musculus | 9 | ALA1938306 | organism-based format | Scientific Literature | |
17. | ALA1942312 | F | Antidiabetic activity in CMC-Na loaded ddY mouse assessed as inhibition of gastric emptying rate at 200 mg/kg, po administered 30 mins before administration of test meal measured after 30 mins (Rvb = 52 +/- 3.1%) | Mus musculus | 5 | ALA1938306 | organism-based format | Scientific Literature | |
18. | ALA1942483 | F | Antidiabetic activity in CMC-Na loaded ddY mouse assessed as inhibition of gastric emptying at 200 mg/kg, po administered 30 mins before administration of test meal measured after 30 mins | Mus musculus | 5 | ALA1938306 | organism-based format | Scientific Literature | |
19. | ALA1942484 | F | Inhibition of 14C-U-glucose uptake in rat small intestine at 1 mM after 6 mins relative to control | Rattus norvegicus | 6 | ALA1938306 | tissue-based format | Scientific Literature | |
20. | ALA1942485 | B | Inhibition of alpha-glucosidase activity of maltase in rat small intestinal brush border membrane fraction using maltose as substrate after 30 mins | Rattus norvegicus | 27 | ALA1938306 | assay format | Scientific Literature |